Comments
Loading...
Zevra Therapeutics (ZVRA) Forecast
NewsEarningsZevra Therapeutics (ZVRA) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestZevra Therapeutics (NASDAQ:ZVRA) Stock Quotes, Forecast and News Summary
Zevra Therapeutics Stock (NASDAQ: ZVRA) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Zevra Therapeutics (ZVRA) stock?
You can purchase shares of Zevra Therapeutics (NASDAQ:ZVRA) through any online brokerage.
Who are Zevra Therapeutics (ZVRA) competitors?
Other companies in Zevra Therapeutics’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Third Harmonic Bio (NASDAQ:THRD), Theravance Biopharma (NASDAQ:TBPH), GH Research (NASDAQ:GHRS) and SNDL (NASDAQ:SNDL).
What is the forecast, or price target, for Zevra Therapeutics (ZVRA) stock?
Zevra Therapeutics has a consensus price target of $21.00.
What is the current price for Zevra Therapeutics (ZVRA)?
The stock price for Zevra Therapeutics (NASDAQ: ZVRA) is $8.655 last updated December 26, 2024 at 10:40 AM EST.
Does Zevra Therapeutics (ZVRA) pay a dividend?
There are no upcoming dividends for Zevra Therapeutics.
When is Zevra Therapeutics (NASDAQ:ZVRA) reporting earnings?
Zevra Therapeutics’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
Is Zevra Therapeutics (ZVRA) going to split?
There is no upcoming split for Zevra Therapeutics.
What sector and industry does Zevra Therapeutics (ZVRA) operate in?
Zevra Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.